Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/20174566

Download in:

View as

General Info

PMID
20174566